nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An interdisciplinary approach to treating prostate cancer
|
Kibel, Adam S. |
|
2005 |
1-20 |
6S |
p. 13-18 6 p. |
artikel |
2 |
Antimicrobial therapy for bacterial and nonbacterial prostatitis
|
Fowler Jr, Jackson E. |
|
2002 |
1-20 |
6S |
p. 24-26 3 p. |
artikel |
3 |
A review of the development and validation of the national institutes of health chronic prostatitis symptom index
|
Litwin, Mark S. |
|
2002 |
1-20 |
6S |
p. 14-18 5 p. |
artikel |
4 |
Bladder training biofeedback and pelvic floor myalgia
|
Nadler, Robert B |
|
2002 |
1-20 |
6S |
p. 42-43 2 p. |
artikel |
5 |
Chronic prostatitis: epidemiology and role of infection
|
KRIEGER, J.O.H.N.N |
|
2002 |
1-20 |
6S |
p. 8-12 5 p. |
artikel |
6 |
Classification (traditional and national institutes of health) and demographics of prostatitis
|
Schaeffer, Anthony J. |
|
2002 |
1-20 |
6S |
p. 5-6 2 p. |
artikel |
7 |
Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome
|
Nickel, J.Curtis |
|
2002 |
1-20 |
6S |
p. 20-22 3 p. |
artikel |
8 |
Clinical pharmacokinetics of estramustine phosphate
|
Gunnarsson, Per Olov |
|
1984 |
1-20 |
6S |
p. 22-27 6 p. |
artikel |
9 |
Clinical toxicity and long-term results of Emcyt therapy for prostate cancer
|
Slack, Nelson H. |
|
1984 |
1-20 |
6S |
p. 73-77 5 p. |
artikel |
10 |
CME-2
|
|
|
2002 |
1-20 |
6S |
p. 45-49 5 p. |
artikel |
11 |
CME-1
|
|
|
2002 |
1-20 |
6S |
p. iv-v nvt p. |
artikel |
12 |
Control of response to estramustine phosphate therapy through cytology and DNA analysis of cell nuclei in prospective study
|
Leistenschneider, W. |
|
1984 |
1-20 |
6S |
p. 81-88 8 p. |
artikel |
13 |
Conventional Treatments of Localized Prostate Cancer
|
Zerbib, Marc |
|
2008 |
1-20 |
6S |
p. S25-S35 11 p. |
artikel |
14 |
Cytotoxic properties of estramustine unrelated to alkylating and steroid constituents
|
Tew, Kenneth D. |
|
1984 |
1-20 |
6S |
p. 28-33 6 p. |
artikel |
15 |
Discussion following Dr. Datta’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 28- 1 p. |
artikel |
16 |
Discussion following Dr. Fowler’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 26- 1 p. |
artikel |
17 |
Discussion following Dr. Krieger’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 13- 1 p. |
artikel |
18 |
Discussion following Dr. Litwin’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 18-19 2 p. |
artikel |
19 |
Discussion following Dr. Nadler’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 44- 1 p. |
artikel |
20 |
Discussion following Dr. Nickel’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 22-23 2 p. |
artikel |
21 |
Discussion following Dr. Pontari’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 33-34 2 p. |
artikel |
22 |
Discussion following Dr. Schaeffer’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 6-7 2 p. |
artikel |
23 |
Discussion following Dr. Shoskes’ presentation
|
|
|
2002 |
1-20 |
6S |
p. 37- 1 p. |
artikel |
24 |
Discussion following Dr. Zeitlin’s presentation
|
|
|
2002 |
1-20 |
6S |
p. 41- 1 p. |
artikel |
25 |
Effect of previous treatment on Estracyt response in advanced Stage D prostatic carcinoma
|
Mittelman, Arnold |
|
1984 |
1-20 |
6S |
p. 78-80 3 p. |
artikel |
26 |
Estramustine phosphate as primary therapy for metastatic prostate cancer
|
Benson Jr., Ralph C. |
|
1984 |
1-20 |
6S |
p. 69-72 4 p. |
artikel |
27 |
Estramustine phosphate—historical overview
|
Fex, H. |
|
1984 |
1-20 |
6S |
p. 4-5 2 p. |
artikel |
28 |
Estramustine phosphate in prostate cancer
|
Smith, P.H. |
|
1984 |
1-20 |
6S |
p. 64-68 5 p. |
artikel |
29 |
Evaluating Localized Prostate Cancer and Identifying Candidates for Focal Therapy
|
Sartor, A. Oliver |
|
2008 |
1-20 |
6S |
p. S12-S24 13 p. |
artikel |
30 |
Faculty Disclosures
|
|
|
2008 |
1-20 |
6S |
p. vi- 1 p. |
artikel |
31 |
Faculty List
|
|
|
2008 |
1-20 |
6S |
p. iv- 1 p. |
artikel |
32 |
Focal Therapy for Prostate Cancer: Analysis by an International Panel
|
Scardino, Peter T. |
|
2008 |
1-20 |
6S |
p. S1-S2 2 p. |
artikel |
33 |
Future directions in the treatment of androgen-independent prostate cancer
|
Petrylak, Daniel P. |
|
2005 |
1-20 |
6S |
p. 8-12 5 p. |
artikel |
34 |
Heat therapy in the treatment of prostatitis
|
Zeitlin, Scott I. |
|
2002 |
1-20 |
6S |
p. 38-40 3 p. |
artikel |
35 |
Histopathology of prostate cancer: Prediction of malignant behavior and correlation with ultrasonography
|
Miller, Gary J. |
|
1989 |
1-20 |
6S |
p. 18-26 9 p. |
artikel |
36 |
Immunologic effects of estramustine phosphate
|
Kalland, Terje |
|
1984 |
1-20 |
6S |
p. 39-45 7 p. |
artikel |
37 |
Inflammation and anti-inflammatory therapy in chronic prostatitis
|
A. Pontari, Michel |
|
2002 |
1-20 |
6S |
p. 29-33 5 p. |
artikel |
38 |
Initial clinical studies with estramustine phosphate
|
Nilsson, Torgny |
|
1984 |
1-20 |
6S |
p. 49-50 2 p. |
artikel |
39 |
Introduction
|
Debruyne, Frans M.J. |
|
2005 |
1-20 |
6S |
p. 1- 1 p. |
artikel |
40 |
Introduction and overview
|
Crawford, E. David |
|
1989 |
1-20 |
6S |
p. 2-6 5 p. |
artikel |
41 |
Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer
|
Sandberg, Avery A. |
|
1984 |
1-20 |
6S |
p. 11-21 11 p. |
artikel |
42 |
Mode of action of emcyt
|
Høisaeter, Per Age |
|
1984 |
1-20 |
6S |
p. 46-48 3 p. |
artikel |
43 |
New Treatments for Localized Prostate Cancer
|
Marberger, Michael |
|
2008 |
1-20 |
6S |
p. S36-S43 8 p. |
artikel |
44 |
Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases
|
Eisenkraft, Shimon |
|
1984 |
1-20 |
6S |
p. 51-53 3 p. |
artikel |
45 |
Overview summary statement
|
Schaeffer, Anthony J. |
|
2002 |
1-20 |
6S |
p. 1-4 4 p. |
artikel |
46 |
Phytotherapy in chronic prostatitis
|
Shoskes, Daniel A. |
|
2002 |
1-20 |
6S |
p. 35-37 3 p. |
artikel |
47 |
Preclinical pharmacology and toxicology of estramustine phosphate
|
Müntzing, Jonas |
|
1984 |
1-20 |
6S |
p. 6-10 5 p. |
artikel |
48 |
Preface
|
Murphy, Gerald P. |
|
1984 |
1-20 |
6S |
p. 3- 1 p. |
artikel |
49 |
Prostate Cancer: Epidemiology and Health-related Quality of Life
|
Penson, David F. |
|
2008 |
1-20 |
6S |
p. S3-S11 9 p. |
artikel |
50 |
Questions and answers
|
|
|
1989 |
1-20 |
6S |
p. 32- 1 p. |
artikel |
51 |
Role of α-blockers in the treatment of chronic prostatitis
|
Datta, Nand S. |
|
2002 |
1-20 |
6S |
p. 27-28 2 p. |
artikel |
52 |
Serum prostate-specific antigen: Its use in diagnosis and management of prostate cancer
|
Lange, Paul H. |
|
1989 |
1-20 |
6S |
p. 13-17 5 p. |
artikel |
53 |
Specific binding of estramustine to prostatic proteins
|
Forsgren, Björn |
|
1984 |
1-20 |
6S |
p. 34-38 5 p. |
artikel |
54 |
The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer
|
Berry, William R. |
|
2005 |
1-20 |
6S |
p. 2-7 6 p. |
artikel |
55 |
Title page
|
|
|
2008 |
1-20 |
6S |
p. i- 1 p. |
artikel |
56 |
Transrectal ultrasound in management of prostate cancer
|
Scardino, Peter T. |
|
1989 |
1-20 |
6S |
p. 27-31 5 p. |
artikel |
57 |
Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial Institute
|
Murphy, Gerald P. |
|
1984 |
1-20 |
6S |
p. 54-63 10 p. |
artikel |
58 |
Use of transrectal ultrasound in diagnosis, guided biopsy, staging, and screening of prostate cancer
|
Lee, Fred |
|
1989 |
1-20 |
6S |
p. 7-12 6 p. |
artikel |